Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples